Warning: The NCBI web site requires JavaScript to function. more...
Specific antibody response of mice after immunization with COS-7 cell derived avian influenza virus (H5N1) recombinant proteins.
Horthongkham N, Srihtrakul T, Athipanyasilp N, Siritantikorn S, Kantakamalakul W, Poovorawan Y, Sutthent R.
J Immune Based Ther Vaccines. 2007 Oct 3;5:10.
Related citations
Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus.
Wei CJ, Xu L, Kong WP, Shi W, Canis K, Stevens J, Yang ZY, Dell A, Haslam SM, Wilson IA, Nabel GJ.
J Virol. 2008 Jul;82(13):6200-8. Epub 2008 Apr 16.
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
Virology. 2008 Oct 25;380(2):412-20. Epub 2008 Sep 10.
Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice.
Tao P, Luo M, Zhu D, Qu S, Yang Z, Gao M, Guo D, Pan Z.
Viral Immunol. 2009 Jul;22(4):273-81.
Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity.
Nayak B, Kumar S, DiNapoli JM, Paldurai A, Perez DR, Collins PL, Samal SK.
J Virol. 2010 Mar;84(5):2408-20. Epub 2009 Dec 23.
Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase.
Tsai C, Caillet C, Hu H, Zhou F, Ding H, Zhang G, Zhou B, Wang S, Lu S, Buchy P, Deubel V, Vogel FR, Zhou P.
Vaccine. 2009 Nov 12;27(48):6777-90. Epub 2009 Sep 2.
A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice.
Zheng L, Wang F, Yang Z, Chen J, Chang H, Chen Z.
BMC Infect Dis. 2009 Feb 12;9:17.
Preparation and immune activity analysis of H5N1 subtype avian influenza virus recombinant protein-based vaccine.
Xie QM, Ji J, Du LQ, Cao YC, Wei L, Xue CY, Qin JP, Ma JY, Bi YZ.
Poult Sci. 2009 Aug;88(8):1608-15.
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus.
Biesova Z, Miller MA, Schneerson R, Shiloach J, Green KY, Robbins JB, Keith JM.
Vaccine. 2009 Oct 19;27(44):6234-8. Epub 2009 Aug 15.
Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.
Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, Kumar NM, Pushko P, Smith G, Tumpey TM, Ross TM.
PLoS One. 2008 Jan 30;3(1):e1501.
[Immunological evaluation of vector-expressed M2 and HA genes of H5N1 influenza virus in mice].
Guo J, Yao L, Chen A, Xu Y, Liu X, Shu Y, Zhang Z.
Sheng Wu Gong Cheng Xue Bao. 2010 May;26(5):649-56. Chinese.
Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.
Richards KA, Chaves FA, Sant AJ.
J Virol. 2009 Jul;83(13):6566-77. Epub 2009 Apr 22.
Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.
Patel A, Tran K, Gray M, Li Y, Ao Z, Yao X, Kobasa D, Kobinger GP.
Vaccine. 2009 May 18;27(23):3083-9. Epub 2009 Apr 1.
[Study on immunogenicity of a recombinant adenovirus vaccine containing neuraminidase gene of H5N1 influenza virus (A/Anhui/1/2005) in mice].
Ma J, Zhang XG, Li KB, Zhang XM, Wang M, Bai T, Yang L, Xu H, Shu YL, Zeng Y.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009 Dec;23(6):449-51. Chinese.
Immunogenicity of avian H5N1 influenza virus recombinant vaccines in cats.
Uhl EW, Harvey SB, Michel F, Perozo Y, Gabbard J, Tompkins SM, Hogan RJ.
Viral Immunol. 2010 Apr;23(2):221-6.
Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.
Johansson BE.
Vaccine. 1999 Apr 9;17(15-16):2073-80.
[Construction of bicistronic eukaryotic expression vector containing HA and M2 genes derived from high pathogenic avian influenza virus (HPAI) H5N1 (Anhui strain)and its efficient expression in mammalian cells].
Liu Y, Zhang K, Tan WJ, Wang HJ, Shu YL, Hu GX, Ruan L.
Bing Du Xue Bao. 2008 Nov;24(6):415-20. Chinese.
Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza.
Steel J, Lowen AC, Pena L, Angel M, Solórzano A, Albrecht R, Perez DR, García-Sastre A, Palese P.
J Virol. 2009 Feb;83(4):1742-53. Epub 2008 Dec 10.
Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria.
Shen S, Mahadevappa G, Oh HL, Wee BY, Choi YW, Hwang LA, Lim SG, Hong W, Lal SK, Tan YJ.
J Med Virol. 2008 Nov;80(11):1972-83.
Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.
Ge J, Deng G, Wen Z, Tian G, Wang Y, Shi J, Wang X, Li Y, Hu S, Jiang Y, Yang C, Yu K, Bu Z, Chen H.
J Virol. 2007 Jan;81(1):150-8. Epub 2006 Oct 18.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on